IMO, it might be more cost effective to run a shor
Post# of 148112
(Total Views: 406)
Posted On: 09/18/2020 6:10:15 PM
IMO, it might be more cost effective to run a short human trial to evaluate leronlimab in relation to crossing the blood brain barrier prior to starting costly clinical trials. But if I remember correctly, Dr L’s dad and possibly another doctor wanted to start the trials because they believe it crosses for X reason. I don’t remember the exact reason.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼